The data published in Cancer Incidence in Five Continents for various Indian registries for different periods and/or publication by the individual registries served as the source material. find more The mean annual percentage change in the incidence rates was computed using the relative difference between two time periods (latest and furthermost)

and estimation of annual percentage change (EAPC) was also computed by the Poisson regression model. In 1998-2005, the incidence rate of cancer of the corpus uteri [age standardized rate (ASR)], was highest in Delhi and lowest in Pune and Imphal West (4.4 and 0.0 per 100 000 woman-years, respectively). The incidence rate in most of the registries between the two time periods showed an increase with few exceptions. Estimation of EAPC carried out in Mumbai, Chennai, and Bangalore PBCRs for the period 1983-2002 showed statistically significant increases in crude rate, ASR, and age-specific incidence rates (ASIR). The largest EAPC in ASR was in Bangalore (6.4%) and the smallest in Chennai (1.8%). Incidence trends for cancer of the corpus uteri

appeared to result from an increase in the prevalence of risk factors and in improvement in diagnostic procedures. Most cancer of the corpus uteri is environmental in origin. Limiting fat consumption and avoiding excess energy intake may result in some reduction in the incidence of cancer of the corpus uteri. European Journal of Cancer Prevention 20:25-32 (C) 2011 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.”
“The Napabucasin Ontario HIV

Treatment Network Cohort Study (OCS) is an observational, open dynamic cohort of people who are receiving medical care for human immunodeficiency virus (HIV) infection in Ontario, Canada. Established in the mid-1990s, the OCS has its roots in AIDS activists’ demands for research that would improve the quality of life of people living with Bcl-2 inhibitor HIV while respecting their privacy. It is a collaborative and community-driven study, including a Governance Committee made up of people with HIV and other stakeholders that evaluates analysis project proposals for community relevance and ethics. From 1995 to 2010, a total of 5644 participants were enrolled and 27 720 person-years of observation were accumulated; follow-up will continue until at least 2015. In the initial years of study, the focus was on clinical data from medical chart reviews. It has since evolved into a comprehensive study that collects extensive de-identified information on clinical, laboratory and psychosocial and behavioural measures based on medical chart abstractions, interviews using a standardized questionnaire and linkage with external administrative health databases in Ontario. Interested collaborators are encouraged to submit analysis project proposals as instructed on the study website (www.ohtncohortstudy.ca).